日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Conformational isomerism breaks the electrolyte solubility limit and stabilizes 4.9 V Ni-rich layered cathodes

构象异构现象打破了电解液溶解度极限,并稳定了4.9 V富镍层状正极材料。

Lu, Ziyang; Yang, Huijun; Sun, Jianming; Okagaki, Jun; Choe, Yoongkee; Yoo, Eunjoo

Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R Domain

通过嵌合IL7R结构域激活CAR-T细胞中的细胞内在信号传导

Stamatia C Vorri,Natalie J Holl,Michael Leeming,Petya Apostolova,Andrew Marple,Jonas W Ravich,Ata Canbaz,Ruyan Rahnama,Jun Choe,Arjun Modi,Adam D Fearnow,Scott T R Walsh,Erika L Pearce,Ravi Varadhan,Challice L Bonifant

Early Detection of Secondary Bladder Urothelial Carcinoma and Disseminated Bone Metastases with Normal Prostate-Specific Antigen Level after Pelvic Salvage Radiotherapy in Prostate Cancer

前列腺癌盆腔挽救性放疗后,前列腺特异性抗原水平正常时,早期发现继发性膀胱尿路上皮癌和骨转移

Shin, Teak Jun; Choe, Misun; Kim, Byung Hoon; Byun, Sang Jun

Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 Agents

ACE2 的变构结合剂是有前途的抗 SARS-CoV-2 药物

Joshua E Hochuli, Sankalp Jain, Cleber Melo-Filho, Zoe L Sessions, Tesia Bobrowski, Jun Choe, Johnny Zheng, Richard Eastman, Daniel C Talley, Ganesha Rai, Anton Simeonov, Alexander Tropsha, Eugene N Muratov, Bolormaa Baljinnyam, Alexey V Zakharov

Discovery of small molecule inhibitors that effectively disrupt IQGAP1-Cdc42 interaction in breast cancer cells

发现可有效破坏乳腺癌细胞中 IQGAP1-Cdc42 相互作用的小分子抑制剂

Samar Sayedyahossein, Jessica Smith, Elena Barnaeva, Zhigang Li, Jun Choe, Michael Ronzetti, Christopher Dextras, Xin Hu, Juan Marugan, Noel Southall, Bolormaa Baljinnyam, Louise Thines, Andy D Tran, Marc Ferrer, David B Sacks

Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents

ACE2 的变构结合剂有望成为抗 SARS-CoV-2 药物

Joshua E Hochuli, Sankalp Jain, Cleber Melo-Filho, Zoe L Sessions, Tesia Bobrowski, Jun Choe, Johnny Zheng, Richard Eastman, Daniel C Talley, Ganesha Rai, Anton Simeonov, Alexander Tropsha, Eugene N Muratov, Bolormaa Baljinnyam, Alexey V Zakharov

Hybrid In Silico Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 Variants

混合计算机模拟方法揭示多种 SARS-CoV-2 变体的新型抑制剂

Sankalp Jain, Daniel C Talley, Bolormaa Baljinnyam, Jun Choe, Quinlin Hanson, Wei Zhu, Miao Xu, Catherine Z Chen, Wei Zheng, Xin Hu, Min Shen, Ganesha Rai, Matthew D Hall, Anton Simeonov, Alexey V Zakharov

Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma

比较直接抗病毒疗法治疗伴或不伴丙型肝炎相关肝细胞癌的疗效和安全性

Kwan, Byung Soo; Kim, Jeong Han; Park, Seong Jun; Choe, Won Hyeok; Kwon, So Young; Yoo, Byung-Chul

Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR

韩国首例导致新冠病毒感染三级传播的病例:采用定量RT-PCR监测洛匹那韦/利托那韦治疗新冠病毒感染性肺炎的应用

Lim, Jaegyun; Jeon, Seunghyun; Shin, Hyun Young; Kim, Moon Jung; Seong, Yu Min; Lee, Wang Jun; Choe, Kang Won; Kang, Yu Min; Lee, Baeckseung; Park, Sang Joon

A classical swine fever virus E2 fusion protein produced in plants elicits a neutralizing humoral immune response in mice and pigs.

植物中产生的经典猪瘟病毒 E2 融合蛋白可引起小鼠和猪的中和性体液免疫反应

Park Youngmin, Lee Sangmin, Kang Hyangju, Park Minhee, Min Kyungmin, Kim Nam Hyung, Gu Sungmin, Kim Jong Kook, An Dong-Jun, Choe SeEun, Sohn Eun-Ju